Market Cap (In USD)
2.72 Million
Revenue (In USD)
92.99 Thousand
Net Income (In USD)
-1.51 Million
Avg. Volume
280.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0125-0.0675
- PE
- -
- EPS
- -
- Beta Value
- 0.414
- ISIN
- CA62857B1094
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. John Campbell
- Employee Count
- -
- Website
- https://www.myndsciences.com
- Ipo Date
- 2021-09-22
- Details
- MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. The company is headquartered in Kelowna, Canada.
More Stocks
-
PPCPPC Ltd
PPC
-
ATERAterian, Inc.
ATER
-
GLADZ
-
2438Asukanet Co., Ltd.
2438
-
MEDHLP
-
600676
-
SELEC
-
GAINN